Pharmaron Group News Today

Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm - read this article along with other careers information, tips and advice on BioSpace

Continues to strengthen the global chemistry and manufacturing capabilities and capacities Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that it has

Press release content from Business Wire. The AP news staff was not involved in its creation.

Continues to strengthen the global chemistry and manufacturing capabilities and capacitiesBEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm group.The Cramli...

Pharmaron Acquires Bioprocessing Site from AbbVie Source: ljubaphoto/Getty Images March 5, 2021 Pharmaron, an R&D service provider for the life sciences industry with operations in China, the U.S., and the U.K., reports that it has entered into an agreement to acquire Allergan Biologics (ABL) in Liverpool from AbbVie for $118.7 million in cash. The deal is set to close in the second quarter of 2021. The ABL site consists of a cGMP biomanufacturing facility that has held MHRA biologic manufactu...

Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie Continues to build integrated capabilities platform for Cell Gene Therapy Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ("Pharmaron") announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited ("The ABL site") in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the s...